Stock Chart
ADVM
Type: SELL wallstreet
Strike: $5
Premium: $0.05
Expiry: Mar 20, 2026
Target: $5
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ADVM - Adverum Biotechnologies, Inc. Common Stock
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations …
Key Statistics
More ADVM Analysis
This ADVM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ADVM's price movements with trendlines, gamma walls, and key support/resistance levels.